February 23, 2022 — The LEGO Foundation has announced it will donate 600 LEGO MRI Scanners to hospitals worldwide to help children cope with the uncertainty of having a magnetic resonance imaging (MRI) scan.

February 22, 2022 — A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.

February 22, 2022 — The Global Mammography Devices Market stood at $2744.07 million in 2020 and is expected to grow at a steady CAGR of 5.78% during the forecast period. The growth of mammography devices can be attributed to the growing prevalence of breast cancer across the globe. Cancer is a terminal disease and under many cases early diagnosis is very difficult, making it more life threatening.

February 22, 2022 — Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas with natural nanoparticle-based immunotherapy, thus suppressing growth of the deadly tumor, inducing anti-tumor immunity and prolonging survival in animal models, a research team at Massachusetts General Hospital (MGH) has discovered.

February 21, 2022 — The global diagnostic imaging market is projected to reach $35 billion by 2026 from $26.6 billion in 2020, at a CAGR of 5.7% from 2021 to 2026.

February 18, 2022 — The Nuclear Medicine Europe (NMEu) Emergency Response Team held a call on February 14 on the unplanned HFR outage that resulted in cancellation of the planned HFR first operating cycle of 2022.

February 18, 2022 — RaySearch has a strong position in the radiotherapy market in Canada with a market share of approximately 25 percent. Charles-Le Moyne hospital has been a RayStation customer since 2018.

February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson).

February 18, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, announced publication of key results from its Phase 3 SPOTLIGHT trial of 

Do you have a clinical case you’d like to share with ITN's audience? If so, please send high-resolution images and a brief written case study to [email protected]

You can take a look at our premier Clinical Case of the Month here.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now